Detalhe da pesquisa
1.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
; 36(10): 100241, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343766
2.
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Mod Pathol
; 35(8): 1092-1100, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145197
3.
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.
Int J Mol Sci
; 22(2)2021 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418978
4.
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
J Pathol
; 246(2): 244-253, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015382
5.
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.
Prostate
; 76(15): 1409-19, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325561
6.
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.
Mod Pathol
; 29(8): 904-14, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27174589
7.
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.
Prostate
; 75(11): 1206-15, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939393
8.
DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma.
J Urol
; 192(6): 1842-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046620
9.
Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.
Hum Mutat
; 34(1): 149-56, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22887727
10.
Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality.
Prostate
; 73(9): 905-12, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334893
11.
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
Adv Anat Pathol
; 20(1): 39-44, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23232570
12.
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
J Pathol
; 227(1): 53-61, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294438
13.
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
J Pathol
; 227(3): 286-97, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22553170
14.
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Anticancer Drugs
; 23(5): 543-52, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481061
15.
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.
Hum Pathol
; 122: 84-91, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176252
16.
Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence.
BJU Int
; 108(8 Pt 2): E202-10, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443656
17.
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.
Nat Commun
; 12(1): 184, 2021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420073
18.
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer.
Prostate
; 70(10): 1134-45, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20503398
19.
A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
Cell Death Discov
; 6: 65, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793395
20.
Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
J Exp Clin Cancer Res
; 39(1): 33, 2020 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041631